Plus Therapeutics is a pharmaceutical company that specializes in treating cancer and other diseases by developing, manufacturing, and commercializing medicinal treatments. Their flagship product is Rhenium-186 NanoLiposome, a patented radiotherapy with applications in recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The firm has a partnership agreement with NanoTx, Corp. to manufacture and sell NanoTx's glioblastoma treatment.